Kernhistine: Medicine to treat Meniere syndrome

2021-06-17 02:53 PM

Kernhistine: Medicine to treat Meniere's syndrome (dizziness with nausea/vomiting, difficulty hearing or hearing loss, tinnitus). Symptoms of vestibular vertigo (dizziness with nausea or vomiting, even when standing still).

Producer

Kern Pharma.

Ingredient

Betahistine dihydrochloride.

Indications/uses

Meniere's syndrome (dizziness with nausea/vomiting, difficulty hearing or hearing loss, tinnitus).

Symptoms of vestibular vertigo (dizziness with nausea or vomiting, even when standing still).

Dosage/instructions for use

Adults: 1-2 tablets of 8mg x 3 times/day or ½ - 1 tablet of 16mg x 3 times/day; dose range 24-48 mg/day, divided into several doses.

Children < 18 years old: not recommended.

If you forget to take a dose: do not take a double dose to make up for the missed dose.

How to use

Should be taken with food.

Contraindications

Hypersensitivity to drug components.

Adrenal neoplasms are known as pheochromocytoma.

Caution

The patient has a history of peptic ulcer, bronchial asthma.

Pregnancy: not recommended, unless absolutely necessary.

Breastfeeding: weighing benefits and risks.

When driving or operating machinery.

Side Effects

Headache; nausea, indigestion; hypersensitivity reactions; insomnia; palpitations.

Interactive

MAOIs may increase the effects of betahistine.

Betahistine may affect the effectiveness of some of the antihistamines.

Classification

Dizziness/Peripheral vasodilators & brain activators.

Presentation/Packaging

Kernhistine 16mg - Tablets 16mg.

Kernhistine 8mg - Tablets 8mg.